There are 2949 resources available
Q&A and live discussion
Presenter: Vlad Voiculescu
Session: How patient advocates can improve equal access to care and services across Europe and beyond: Concrete examples of success stories
Resources:
Webcast
Using humanised mice to study immune-cancer interactions
Presenter: Anthony Rongvaux
Session: Preclinical models for unanswered clinical questions
Resources:
Slides
Webcast
The role of stem cells in cancer prevention and therapies
Presenter: Eduard Batlle
Session: Preclinical models for unanswered clinical questions
Resources:
Slides
Webcast
Intravital imaging for insights into cancer cell behaviour in real time
Presenter: Jacco van Rheenen
Session: Preclinical models for unanswered clinical questions
Resources:
Slides
Webcast
Oncotaxi: Safe and free transport for cancer patients to hospitals and clinics during pandemia time
Presenter: Agata Polinska
Session: How patient advocates can improve equal access to care and services across Europe and beyond: Concrete examples of success stories
Resources:
Slides
Webcast
Early stage NSCLC immunotherapy: Which biomarkers matter?
Presenter: Julie Brahmer
Session: Breakthroughs in immunotherapy for non-metastatic NSCLC
Resources:
Slides
Webcast
Dealing with comorbidities and toxicities in stage I-III NSCLC
Presenter: Dirk De Ruysscher
Session: Breakthroughs in immunotherapy for non-metastatic NSCLC
Resources:
Slides
Webcast
Selection strategies for immunotherapy in prostate cancer
Presenter: Susan Slovin
Session: Unlocking precision medicine for metastatic prostate cancer
Resources:
Slides
Webcast
Future strategies: Sequencing versus combinations in targeted and immune therapy
Presenter: Paolo Ascierto
Session: Management of melanoma in 2030: Toxicity, resistance, best biomarkers and next steps
Resources:
Slides
Webcast
Management and learnings from toxicity?
Presenter: Caroline Robert
Session: Management of melanoma in 2030: Toxicity, resistance, best biomarkers and next steps
Resources:
Slides
Webcast